Free 7-day Trial
All Articles and Columns »

Weekly CEO Sells Highlight: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, and Laboratory Corporation of America Holdings

GuruFocus

GuruFocus

308 followers
According to GuruFocus Insider Data, these are the largest CEO sales during the past week: Orexigen Therapeutics Inc, Gas Natural Inc, The Middleby Corporation, and Laboratory Corporation of America Holdings Orexigen Therapeutics, Inc. (OREX): President and CEO Michael Narachi sold 150,000 Shares

President and CEO of Orexigen Therapeutics, Inc. (OREX) Michael Narachi sold 150,000 shares on 07/13/2012 at an average price of $6.7. OREXIGEN THERAPEUTICS, INC. is a biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system disorders, including obesity. Orexigen Therapeutics, Inc. has a market cap of $392.4 million; its shares were traded at around $7.06 with and P/S ratio of 114.5.

Orexigen Therapeutics Inc reported net loss of $10.4 million and revenues of $857,000 for their 2012 first quarter results.

President and CEO Michael Narachi sold 375,000 shares of OREX stock in June and July. Chief Business Officer Joseph P Hagan sold 241,309 shares of OREX stock in June and July.

Gas Natural Inc (EGAS): Chairman and CEO, 10% Owner Richard M Osborne sold 100,000 Shares

Chairman and CEO, 10% Owner of Gas Natural Inc (EGAS) Richard M Osborne sold 100,000 shares on 07/12/2012 at an average price of $10.1. Gas Natural Inc., formerly known as Energy, Inc., distributes and sells natural gas to end-use residential, commercial, and industrial customers. Gas Natural Inc has a market cap of $83.1 million; its shares were traded at around $10.2 with a P/E ratio of 24.9 and P/S ratio of 0.8. The dividend yield of Gas Natural Inc stocks is 5.3%. Gas Natural Inc had an annual average earnings growth of 17.1% over the past 10 years.

Gas Natural Inc announced their 2012 first quarter financial results on May 15, 2012. The Company reported net income of $3.3 million and total revenues of $33.8 million.

Chairman and CEO, 10% Owner Richard M Osborne sold 800,000 shares of EGAS stock in July.

The Middleby Corporation (MIDD): CEO, Chairman, President Selim A Bassoul sold 100,000 Shares

CEO, Chairman, President of The Middleby Corporation (MIDD) Selim A Bassoul sold 100,000 shares on 07/06/2012 at an average price of $100. MIDDLEBY CORP. through its subsidiaries and their operating divisions, is engaged in the manufacture and sale of commercial foodservice equipment and beverage merchandisers. The Middleby Corporation has a market cap of $1.86 billion; its shares were traded at around $99.67 with a P/E ratio of 18.4 and P/S ratio of 2.2. The Middleby Corporation had an annual average earnings growth of 25.6% over the past 10 years. GuruFocus rated The Middleby Corporation the business predictability rank of 2.5-star.

The Middleby Corp. reported their 2012 first quarter financial results. The Company reported net earnings of $22.1 million, or $1.20 per share. Net sales for this quarter were $228.8 million.

CEO, Chairman, President Selim A Bassoul sold 154,286 shares of MIDD stock in March, April and July. CFO Timothy John Fitzgerald sold 17,432 shares of MIDD stock from February to May. Director Sabin C Streeter and Director Ryan Levenson sold 3,600 shares of MIDD stock in March and May.

Laboratory Corp. of America Holdings (LH): President & CEO David P King sold 84,800 Shares

President & CEO of Laboratory Corp. of America Holdings (LH) David P King sold 84,800 shares on 07/09/2012 at an average price of $92.11. Laboratory Corporation of America Holdings, is one of the largest independent clinical laboratory company's in the United States. Laboratory Corp. Of America Holdings has a market cap of $8.9 billion; its shares were traded at around $95.23 with a P/E ratio of 14 and P/S ratio of 1.6. Laboratory Corp. Of America Holdings had an annual average earnings growth of 14.8% over the past 10 years. GuruFocus rated Laboratory Corp. Of America Holdings the business predictability rank of 5-star.

Laboratory Corporation announced their 2012 first quarter financial results. The Company reported net earnings for this quarter was $161.6 million and revenues were $1.4 billion.

President & CEO David P King sold 104,800 shares of LH stock in January and July. CFO, EVP William B Hayes sold 93,061 shares of LH stock in March. Chief Information Officer Lidia Fonseca, Chief Legal Officer, Secretary F Samuel Eberts III, Director Wendy E Lane, and Director Jean-luc Belingard sold 7,028 shares of LH stock in May and June.

For the complete list of stocks that bought by their CEOs, go to: Insider Buys.

  • CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
  • Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
  • Double Buys:: Companies that both Gurus and Insiders are buying
  • Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.

» Take a Free Trial of Premium Membership


Rating: 3.7/5 (3 votes)

Comments

Please leave your comment:


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide